Tag: BSE
Zydus Life net profit up 30% to Rs 1,024 crore, revenue...
The company’s revenue from operations stood at Rs 5,269 crore, up 17% as compared to Rs 4,505 crore reported in Q3 FY24
Anthem Biosciences files DRHP for Rs 3,395 crore IPO
The equity shares of Bangalore based company are proposed to be listed on BSE and NSE
Strides Pharma secures approvals for OneSource, India’s first specialty pharma CDMO
Approval from equity shareholders and secured creditors marks a major milestone in the creation of OneSource
Borosil Scientific debuts on stock exchange
This significant milestone marks a new chapter in the company's legacy of innovation and excellence in the scientific and industrial sectors
BSE joins hands with Onsurity to provide affordable healthcare
Onsurity will provide exclusive offers and advisory services on employee healthcare benefits and risk management to the entrepreneurs, the growth engine of the economy
Fortis to demerge its diagnostics business
Fortis Healthcare's board has approved a proposal to separate its diagnostics business into another majority-owned subsidiary, Fortis Malar Hospitals.....
Lupin recalls over 54K vials from US
An enforcement report on US drug regulator’s website says that the ongoing voluntary recall of anti-bacterial injection..
Strides Shasun receives USFDA tentative approval for Efavirenz
Product approval has been granted for the oral dosage produced at the company facility based out of Bangalore...